| Literature DB >> 27618012 |
Lifeng Zhou1,2, Fengmao Chen3,4, Hongyang Pan5, Jianren Ye6,7, Xuejiao Dong8,9, Chunyan Li10,11, Fengling Lin12,13.
Abstract
Bursaphelenchus mucronatus (B. mucronatus) isolates that originate from different regions may vary in their virulence, but their virulence-associated genes and proteins are poorly understood. Thus, we conducted an integrated study coupling RNA-Seq and isobaric tags for relative and absolute quantitation (iTRAQ) to analyse transcriptomic and proteomic data of highly and weakly virulent B. mucronatus isolates during the pathogenic processes. Approximately 40,000 annotated unigenes and 5000 proteins were gained from the isolates. When we matched all of the proteins with their detected transcripts, a low correlation coefficient of r = 0.138 was found, indicating probable post-transcriptional gene regulation involved in the pathogenic processes. A functional analysis showed that five differentially expressed proteins which were all highly expressed in the highly virulent isolate were involved in the pathogenic processes of nematodes. Peroxiredoxin, fatty acid- and retinol-binding protein, and glutathione peroxidase relate to resistance against plant defence responses, while β-1,4-endoglucanase and expansin are associated with the breakdown of plant cell walls. Thus, the pathogenesis of B. mucronatus depends on its successful survival in host plants. Our work adds to the understanding of B. mucronatus' pathogenesis, and will aid in controlling B. mucronatus and other pinewood nematode species complexes in the future.Entities:
Keywords: Bursaphelenchus mucronatus; proteomic; transcriptomic; virulence-associated gene
Mesh:
Substances:
Year: 2016 PMID: 27618012 PMCID: PMC5037770 DOI: 10.3390/ijms17091492
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Transcriptome and proteome data in Bursaphelenchus mucronatus (B. mucronatus).
| Transcriptome Data | Proteome Data | ||
|---|---|---|---|
| Raw reads (pair) | 114,154,604 | Total spectra | 329,868 |
| Clean reads (pair) | 107,097,176 | Peptide number | 16,205 |
| Total nucleotide length (bp) | 9,638,745,840 | Unique number | 12,452 |
| Unigene number | 40,355 | Protein number | 5092 |
| Average length (bp) | 1220 | - | - |
| N50 length (bp) | 2007 | - | - |
Figure 1Validation of RNA-Seq data using real-time quantitative PCR (qRT-PCR). The correlations of the 12 unigenes were detected using RNA-Seq (red bars) and qRT-PCR (blue bars). The 12 column pairs (A–L) from left to right represent the following unigenes: CL8625.Contig1, CL8429.Contig1, CL5894.Contig1, CL5488.Contig2, CL5080.Contig2, CL4567.Contig1, CL3263.Contig1, CL2270.Contig1, CL2264.Contig1, Unigene2394, Unigene2628, and Unigene7511. Error bars show standard deviations.
Figure 2Gene ontology (GO) terms were assigned to the significantly up-regulated transcripts and proteins in highly and weakly virulent Bursaphelenchus mucronatus (B. mucronatus) isolates. The percentage of each category shown is based on the three groups: (a) biological process; (b) cellular component; and (c) molecular function. External ring = protein; internal ring = transcript.
Figure 3Gene ontology (GO) terms were assigned to the significantly down-regulated transcripts and proteins in highly and weakly virulent Bursaphelenchus mucronatus (B. mucronatus) isolates. The percentage of each category shown is based on the three groups: (a) biological process; (b) cellular component; and (c) molecular function. External ring = protein; internal ring = transcript.
KEGG pathways’ enrichment analysis in the Bursaphelenchus mucronatus (B. mucronatus) transcriptome.
| Pathway | DEGs 1 | Genes 2 | Pathway ID | |
|---|---|---|---|---|
| Ribosome | 358 | 520 | 4.35 × 10−30 | ko03010 |
| Amoebiasis | 362 | 576 | 1.50 × 10−19 | ko05146 |
| Pathogenic Escherichia coli infection | 177 | 280 | 1.50 × 10−10 | ko05130 |
| Dilated cardiomyopathy | 213 | 356 | 2.76 × 10−9 | ko05414 |
| Focal adhesion | 452 | 837 | 8.36 × 10−9 | ko04510 |
| Alzheimer’s disease | 295 | 521 | 9.96 × 10−9 | ko05010 |
| Huntington’s disease | 288 | 515 | 7.34 × 10−8 | ko05016 |
| Cardiac muscle contraction | 222 | 387 | 1.67 × 10−7 | ko04260 |
| Hypertrophic cardiomyopathy | 203 | 352 | 3.27 × 10−7 | ko05410 |
| Viral myocarditis | 153 | 255 | 3.55 × 10−7 | ko05416 |
| Extracellular matrix-receptor interaction | 255 | 458 | 6.56 × 10−7 | ko04512 |
| Tight junction | 262 | 475 | 1.29 × 10−6 | ko04530 |
| Oxidative phosphorylation | 242 | 436 | 1.72 × 10−6 | Ko00190 |
| Salmonella infection | 204 | 362 | 2.81 × 10−6 | Ko05132 |
| Melanogenesis | 124 | 208 | 6.87 × 10−6 | Ko04916 |
| Parkinson’s disease | 238 | 435 | 8.45 × 10−6 | Ko05012 |
| Salivary secretion | 162 | 284 | 1.14 × 10−5 | Ko04970 |
| Gastric acid secretion | 187 | 338 | 3.19 × 10−5 | Ko04971 |
| Endocytosis | 223 | 411 | 3.30 × 10−5 | Ko04144 |
| Phagosome | 181 | 328 | 5.14 × 10−5 | Ko04145 |
| Endocrine and other factor-regulated calcium reabsorption | 99 | 166 | 5.43 × 10−5 | Ko04961 |
| Calcium signalling pathway | 260 | 494 | 1.26 × 10−4 | Ko04020 |
| Vibrio cholerae infection | 188 | 349 | 2.19 × 10−4 | Ko05110 |
| Ribosome biogenesis in eukaryotes | 141 | 256 | 3.66 × 10−4 | Ko03008 |
| Vascular smooth muscle contraction | 332 | 654 | 5.38 × 10−4 | Ko04270 |
| African trypanosomiasis | 22 | 29 | 5.83 × 10−4 | Ko05143 |
| GnRH signalling pathway | 133 | 242 | 5.94 × 10−4 | Ko04912 |
| Aminoacyl-tRNA biosynthesis | 73 | 123 | 5.97 × 10−4 | Ko00970 |
| Cholinergic synapse | 109 | 194 | 6.21 × 10−4 | Ko04725 |
| Chemokine signalling pathway | 159 | 296 | 7.57 × 10−4 | Ko04062 |
| Antigen processing and presentation | 98 | 175 | 1.31 × 10−3 | Ko04612 |
| RNA transport | 238 | 463 | 1.34 × 10−3 | Ko03013 |
| Herpes simplex infection | 160 | 303 | 1.92 × 10−3 | Ko05168 |
| Hedgehog signalling pathway | 61 | 104 | 2.40 × 10−3 | Ko04340 |
| Staphylococcus aureus infection | 26 | 38 | 2.42 × 10−3 | Ko05150 |
| Transcriptional misregulation in cancer | 165 | 317 | 3.57 × 10−3 | Ko05202 |
| Phototransduction | 71 | 126 | 4.61 × 10−3 | Ko04744 |
| Prion diseases | 72 | 128 | 4.62 × 10−3 | Ko05020 |
| Pancreatic secretion | 133 | 255 | 7.53 × 10−3 | Ko04972 |
| Morphine addiction | 98 | 183 | 7.88 × 10−3 | Ko05032 |
| Sulphur relay system | 32 | 53 | 1.40 × 10−2 | Ko04122 |
| Olfactory transduction | 109 | 209 | 1.44 × 10−2 | Ko04740 |
| Bacterial invasion of epithelial cells | 131 | 255 | 1.47 × 10−2 | Ko05100 |
| Spliceosome | 274 | 559 | 1.50 × 10−2 | Ko03040 |
| Long-term depression | 71 | 131 | 1.52 × 10−2 | Ko04730 |
| GABAergic synapse | 110 | 212 | 1.69 × 10−2 | Ko04727 |
| Dopaminergic synapse | 148 | 292 | 1.76 × 10−2 | Ko04728 |
| Legionellosis | 73 | 136 | 1.85 × 10−2 | Ko05134 |
| Protein digestion and absorption | 303 | 624 | 1.93 × 10−2 | Ko04974 |
| Glutamatergic synapse | 112 | 218 | 2.25 × 10−2 | Ko04724 |
| Toxoplasmosis | 100 | 193 | 2.28 × 10−2 | Ko05145 |
| Retrograde endocannabinoid signalling | 111 | 216 | 2.29 × 10−2 | Ko04723 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 63 | 117 | 2.51 × 10−2 | Ko05412 |
| Type I diabetes mellitus | 8 | 10 | 2.51 × 10−2 | Ko04940 |
| Neuroactive ligand-receptor interaction | 223 | 455 | 2.61 × 10−2 | Ko04080 |
| Influenza A | 155 | 310 | 2.68 × 10−2 | Ko05164 |
| Gap junction | 109 | 214 | 3.19 × 10−2 | Ko04540 |
| Shigellosis | 90 | 176 | 4.27 × 10−2 | Ko05131 |
| ErbB signalling pathway | 99 | 195 | 4.30 × 10−2 | Ko04012 |
| Fc gamma receptor-mediated phagocytosis | 115 | 229 | 4.41 × 10−2 | Ko04666 |
| Synaptic vesicle cycle | 110 | 219 | 4.77 × 10−2 | Ko04721 |
| mRNA surveillance pathway | 169 | 345 | 4.81 × 10−2 | Ko03015 |
| Regulation of actin cytoskeleton | 363 | 766 | 4.98 × 10−2 | Ko04810 |
1 DEGs: Differentially expressed genes which involve in each KEGG pathway; 2 Genes: Expressed genes which involve in each KEGG pathway.
KEGG pathways enrichment analysis in the Bursaphelenchus mucronatus (B. mucronatus) proteome.
| Pathway | DEPs 1 | Proteins 2 | Pathway ID | |
|---|---|---|---|---|
| Metabolic pathways | 444 | 1119 | 2.96 × 10−18 | Ko01100 |
| Valine, leucine and isoleucine degradation | 61 | 111 | 1.39 × 10−8 | Ko00280 |
| Glycolysis/Gluconeogenesis | 67 | 134 | 3.60 × 10−7 | Ko00010 |
| Fatty acid metabolism | 67 | 136 | 7.28 × 10−7 | Ko00071 |
| Pyruvate metabolism | 51 | 98 | 2.05 × 10−6 | Ko00620 |
| Citrate cycle (TCA cycle) | 42 | 76 | 2.17 × 10−7 | Ko00020 |
| β-Alanine metabolism | 38 | 70 | 1.17 × 10−5 | Ko00410 |
| Aminoacyl-tRNA biosynthesis | 26 | 42 | 1.29 × 10−5 | Ko00970 |
| Oxidative phosphorylation | 71 | 160 | 3.72 × 10−5 | Ko00190 |
| Propanoate metabolism | 42 | 84 | 5.74 × 10−5 | Ko00640 |
| Parkinson’s disease | 63 | 150 | 6.58 × 10−4 | Ko05012 |
| Peroxisome | 71 | 174 | 8.22 × 10−4 | Ko04146 |
| Alzheimer’s disease | 67 | 167 | 1.93 × 10−3 | Ko05010 |
| Butanoate metabolism | 28 | 58 | 1.95 × 10−3 | Ko00650 |
| Retinol metabolism | 48 | 113 | 2.13 × 10−3 | Ko00830 |
| Tryptophan metabolism | 41 | 94 | 2.44 × 10−3 | Ko00380 |
| Galactose metabolism | 21 | 41 | 2.85 × 10−3 | Ko00052 |
| Huntington’s disease | 72 | 184 | 2.89 × 10−3 | Ko05016 |
| Arginine and proline metabolism | 40 | 92 | 2.94 × 10−3 | Ko00330 |
| Glyoxylate and dicarboxylate metabolism | 23 | 47 | 3.89 × 10−3 | Ko00630 |
| Peroxisome proliferator-activated signalling pathway | 29 | 63 | 3.99 × 10−3 | Ko03320 |
| Metabolism of xenobiotics by cytochrome P450 | 48 | 116 | 4.02 × 10−3 | Ko00980 |
| Pentose phosphate pathway | 23 | 48 | 5.42 × 10−3 | Ko00030 |
| Drug metabolism–cytochrome P450 | 44 | 107 | 6.59 × 10−3 | Ko00982 |
| Lysine degradation | 27 | 60 | 7.82 × 10−3 | Ko00310 |
| Biosynthesis of unsaturated fatty acids | 17 | 34 | 9.56 × 10−3 | Ko01040 |
| Glutathione metabolism | 40 | 98 | 1.08 × 10−2 | Ko00480 |
| Phenylalanine metabolism | 26 | 59 | 1.23 × 10−2 | Ko00360 |
| Glycerolipid metabolism | 26 | 59 | 1.23 × 10−2 | Ko00561 |
| Starch and sucrose metabolism | 22 | 49 | 1.61 × 10−2 | Ko00500 |
| Synthesis and degradation of ketone bodies | 7 | 11 | 1.99 × 10−2 | Ko00072 |
| Alanine, aspartate and glutamate metabolism | 20 | 45 | 2.40 × 10−2 | Ko00250 |
| Tyrosine metabolism | 27 | 65 | 2.58 × 10−2 | Ko00350 |
| Mismatch repair | 4 | 5 | 2.92 × 10−2 | Ko03430 |
| Pentose and glucuronate inter conversions | 33 | 83 | 2.93 × 10−2 | Ko00040 |
| Arachidonic acid metabolism | 30 | 75 | 3.36 × 10−2 | Ko00590 |
| Lysosome | 47 | 128 | 4.70 × 10−2 | Ko04142 |
| α-Linolenic acid metabolism | 11 | 23 | 4.91 × 10−2 | Ko00592 |
1 DEPs: Differentially expressed proteins which involve in each KEGG pathway; 2 Proteins: Expressed proteins which involve in each KEGG pathway.
Putative virulence-associated genes in Bursaphelenchus mucronatus (B. mucronatus).
| Gene ID | Annotation | Fold Change Bm5:Bm7 | |
|---|---|---|---|
| Protein | RNA | ||
| Uni5244 | Glutathione peroxidase | 3.65 | 1.60 |
| CL3566.Contig2 | Expansin-like protein | 1.79 | 1.45 |
| CL4567.Contig1 | Fatty acid- and retinol-binding protein | 11.66 | 1.94 |
| CL5080.Contig2 | β-1,4-Endoglucanase | 5.34 | 1.51 |
| CL8429.Contig1 | Peroxiredoxin | 4.38 | 1.41 |
Figure 4Influence of RNAi knockdowns of fatty acid- and retinol-binding protein (FAR) and β-1,4-endoglucanase (ENG) genes in Bursaphelenchus mucronatus (B. mucronatus). (a) mRNA expression levels of FAR gene in B. mucronatus after exposure to FAR dsRNA- and GFP dsRNA-soaking buffers (expression level of M9 was taken as 100%); (b) mRNA expression levels of the ENG gene in B. mucronatus after exposure to ENG dsRNA-soaking buffers; (c) influence of RNAi on the reproduction efficiency of B. mucronatus; (d) the cumulative mortality rate of Pinus thunbergii seedlings after inoculation with differently treated nematodes. Error bars show standard deviations. Asterisks (*) indicate a significant difference exists between target dsRNA treatments and controls (p-value < 0.001).